Pfizer China announced that the China National Drug Administration (CNDA) has granted approval of IBRANCE® (palbocic...
Singapore – DotBio, a new company focused on the development of novel immuno-oncology drugs based on humanize...
MedPacto, that announced today a clinical collaboration with AstraZeneca to evaluate the safety and efficacy of MedPacto...
Singapore – The European Commission approves Pfizer's TRAZIMERA, a biosimilar of Roche's cance...
Singapore- The FDA accepts for review Nektar Therapeutics' marketing application seeking approval for NK...
Singapore – The FDA approves Agios Pharmaceuticals' TIBSOVO (ivosidenib) for the treatment of adult pati...
Singapore – US Food and Drug Administration approves Pfizer’s Neupogen biosimilar Nivestym and is expected t...
Singapore – The U.S. Food and Drug Administration approved TPOXX (tecovirimat), the first drug wit...
Immatics Biotechnologies GmbH, a clinical-stage biopharmaceutical company active in the discovery and development of T-c...
Singapore – Eagle Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has granted seve...
OBI Pharma, a Taiwan biopharma company, has announced that the U.S. Food and Drug Administration (FDA) has gra...
Singapore – Eisai and Biogen have announced positive topline results from the Phase II study with BAN2401, an...
Global pharma giant recently announced that its drug candidate for cancer- the combination of Tecentriq (atezolizumab) p...
Singapore – Scientists and clinicians from Singapore institutes are collaborating with C&C Research ...
LUMICKS, a world leader in dynamic single-molecule analysis, has partnered with AstraZeneca and the University of Cambri...
Ascletis BioScience Co., Ltd. and CR Pharmaceutical Commercial Group Co., Ltd. have jointly announced that the two parti...
Singapore - AUM Biosciences (AUM), a new company focused on the development of innovative and affordable oncology m...
Global pharmaceutical company Mylan has announced the US launch of Bivalirudin for Injection, 250 mg singl...
